Advertisement

Table of Contents

July 01, 2013; Volume 65,Issue 3

Review Articles

  • The Therapeutic Potential of Modifying Inflammasomes and NOD-Like Receptors
    Francesco Di Virgilio
    Stephen P. H. Alexander, ASSOCIATE EDITOR, Department of Morphology, Surgery and Experimental Medicine, Section of General Pathology, University of Ferrara, Ferrara, Italy
    Pharmacological Reviews July 2013, 65 (3) 872-905; DOI: https://doi.org/10.1124/pr.112.006171
  • Adenosine Kinase: Exploitation for Therapeutic Gain
    Detlev Boison
    Stephen P.H. Alexander, ASSOCIATE EDITOR, Robert Stone Dow Neurobiology Laboratories, Legacy Research Institute, Portland, Oregon
    Pharmacological Reviews July 2013, 65 (3) 906-943; DOI: https://doi.org/10.1124/pr.112.006361
  • Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects
    Jörg König, Fabian Müller and Martin F. Fromm
    Martin C. Michel, ASSOCIATE EDITOR, Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany
    Pharmacological Reviews July 2013, 65 (3) 944-966; DOI: https://doi.org/10.1124/pr.113.007518
  • Pharmacogenetics and Cardiovascular Disease—Implications for Personalized Medicine
    Julie A. Johnson and Larisa H. Cavallari
    Rhian M. Touyz, ASSOCIATE EDITOR, Center for Pharmacogenomics, Department of Pharmacotherapy and Translational Research and Department of Medicine, Colleges of Pharmacy and Medicine, University of Florida, Gainesville, Florida (J.A.J.); and the Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois (L.H.C.)
    Pharmacological Reviews July 2013, 65 (3) 987-1009; DOI: https://doi.org/10.1124/pr.112.007252
  • The Prostanoid EP4 Receptor and Its Signaling Pathway
    Utako Yokoyama, Kousaku Iwatsubo, Masanari Umemura, Takayuki Fujita and Yoshihiro Ishikawa
    David R. Sibley, ASSOCIATE EDITOR, Cardiovascular Research Institute, Yokohama City University, Yokohama, Japan (U.Y., M.U., T.F., Y.I.); and Department of Cell Biology and Molecular Medicine University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark, New Jersey (K.I.)
    Pharmacological Reviews July 2013, 65 (3) 1010-1052; DOI: https://doi.org/10.1124/pr.112.007195
  • Pharmacokinetic-Pharmacodynamic Modeling of Antibacterial Drugs
    Elisabet I. Nielsen and Lena E. Friberg
    Dan Andersson, ASSOCIATE EDITOR, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden
    Pharmacological Reviews July 2013, 65 (3) 1053-1090; DOI: https://doi.org/10.1124/pr.111.005769
  • The Pharmacology of Regenerative Medicine
    George J. Christ, Justin M. Saul, Mark E. Furth and Karl-Erik Andersson
    Michael A. Nader, ASSOCIATE EDITOR, Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina (G.J.C., K.-E.A.); Wake Forest Innovations, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina (M.E.F.); and Department of Chemical and Paper Engineering, Miami University, Oxford, Ohio (J.M.S.)
    Pharmacological Reviews July 2013, 65 (3) 1091-1133; DOI: https://doi.org/10.1124/pr.112.007393

IUPHAR Nomenclature Report

  • International Union of Basic and Clinical Pharmacology. LXXXVIII. G Protein-Coupled Receptor List: Recommendations for New Pairings with Cognate Ligands
    Anthony P. Davenport, Stephen P. H. Alexander, Joanna L. Sharman, Adam J. Pawson, Helen E. Benson, Amy E. Monaghan, Wen Chiy Liew, Chidochangu P. Mpamhanga, Tom I. Bonner, Richard R. Neubig, Jean Philippe Pin, Michael Spedding and Anthony J. Harmar
    Eliot H. Ohlstein, ASSOCIATE EDITOR, Clinical Pharmacology Unit, University of Cambridge, Cambridge, United Kingdom (A.P.D.); School of Biomedical Sciences, University of Nottingham Medical School, Nottingham, United Kingdom (S.P.H.A.); The University/BHF Centre for Cardiovascular Science, The Queen’s Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom (J.L.S., A.J.P., H.E.B., A.E.M., W.C.L., C.P.M., A.J.H.); Section on Functional Neuroscience, National Institute of Mental Health, Bethesda, Maryland (T.I.B.); Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (R.R.N.); Department of Molecular Pharmacology, Institute of Functional Genomics, CNRS UMR5203, Universities Montpellier, Montpellier, France (J.P.P.); and Les Laboratoires Servier, Suresnes, France (M.S.)
    Pharmacological Reviews July 2013, 65 (3) 967-986; DOI: https://doi.org/10.1124/pr.112.007179

Erratum

Back to top

In this issue

Jump to

Advertisement